We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 46,925 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
09/3/2018 13:52 | about to go blue. very bullish reversal about to happen here | ssrover | |
09/3/2018 11:49 | Did I hear escape give out a shout earlier?? | seanlander | |
09/3/2018 10:46 | Sweet lord Uri. You have 800k of these in your Sip? Unless you have plenty other funds in your overall pension pot, I'd say you are taking a MASSIVE risk. | jimbobaroony | |
09/3/2018 10:40 | Hopefully Myles will put together a research note on Nuvec soon following yesterday's RNS. | parob | |
09/3/2018 09:38 | MMS bringing it back... | seanlander | |
09/3/2018 09:37 | Here we go! Bouncy bouncy!! | seanlander | |
09/3/2018 09:25 | JimBig SIPP, although stretching it now, over 800k -!I have broke my own rule though, so even if correct and this shoots back up, I am not sticking to my plan and bought too early yesterday, so slap on the wrist for me. Cheers | urigem | |
09/3/2018 09:15 | Blue finish guys!!! | escapetohome | |
09/3/2018 09:15 | Here we go again, we have a dip, I watch others jumping in and I think you're mad and then Monday comes and I have to take my hat off to them! I'm not missing this one. We'll be high 20's next week and regretting being Cautious. IMHO | seanlander | |
09/3/2018 09:02 | Urigem, you seem to have endless funds to invest here! | jimbobaroony | |
09/3/2018 08:28 | Call me madder than a cut snake but I just bought some more | volsung | |
09/3/2018 08:28 | Right lets see what's about - gonna try for 50k at 24 | urigem | |
09/3/2018 08:01 | someone just off loaded 100k @23p what a mug! | urigem | |
09/3/2018 07:56 | Just to add Nicola Duke was pretty much spot on about the last move North, as she expected it to hit 36/37p before pulling back, and that's what we've seen happen. | parob | |
09/3/2018 07:14 | Get the feeling we might push down first thing - If we do i will be adding anything sub 24, I tried to buy late yesterday and nothing avaiable so the last 10 min move was a pure play. even the buys in the morning has to be split several times. I like it when we are moving,if we do push down, i do not see it lasting past the hour, who knows with the AIM- could do anything! | urigem | |
09/3/2018 06:45 | It's worth watching this Vox Markets podcast from the 1st March: From 9 mins 10 seconds, Nicola Duke said she expected a one third pullback from the recent high to 23.5/23.9/24p and "then we should see another leg higher and next time we continue higher we're looking for 46 or 53 on the upside". | parob | |
09/3/2018 06:42 | Thrifty and lean company, so the appointment of Mr Leishman is significant. However you have to remember nuvec is still at an early stage. It shows promise but there is much work to do. Medium and long term the outlook is good, but some short term patience is required. I'm banking on viagra reform securing a revenue stream to progress other projects, but there are many different ways this could all play out. | tp6 | |
08/3/2018 23:10 | Today demonstrates the difficulties faced when investing in AIM. A pretty innocuous but generally positive RNS results in a decent sized drop in share price Maybe this news should have been released as a news update on their website rather than an RNS. Not sure anything within it required an RNS. It was more nice to know. Long term, this will be fine. Short term it will bounce up and down. | jimbobaroony | |
08/3/2018 18:50 | "The Company is delighted to announce the appointment of Andrew Leishman as Head of Nuvec® Development. Having previously worked at Astra Zeneca as a Senior Research Scientist, Andrew brings with him a wealth of research and development expertise to the Company's lead vaccine delivery program. Andrew has worked on a variety of clinical and pre-clinical assets across respiratory, inflammation and oncology for several pharmaceutical companies" For a £21m company like N4, he is a big gun. | hughwilson | |
08/3/2018 17:41 | I agree, just chill. Everyone here is a holder but I have seen some posts from the likes of parob and hugh that have the whiff of a ramp. It was not a "great" RNS..it was simply good. The guy is not ex AZN top brass, he is an experienced pharma guy who was looking for a new job. This went down 8% today, so what..If you're not selling it's irrelevant in the long term. | dplewis1 | |
08/3/2018 17:12 | Back to a market cap of just £21 million. | parob | |
08/3/2018 17:11 | Come on now n4p stop this hissy fitting, you KNOW you want to climb higher.DO SO. | escapetohome | |
08/3/2018 16:30 | He is not top brass from AZ. Of more interest is that he was at Meddimune a couple of years ago, but wouldn't call him a big hitter as such.I'm a holder here and think there's a great story but we can't say "Wow here's a rock star from a FTSE 100 pharma!" | deeppockets | |
08/3/2018 16:02 | Vox Markets Podcast? @VoxPodcast 5m5 minutes ago#N4P @n4pharma had 1 of the most liked RNS's on @VoxMarkets over the last 24 hours........................................... | parob |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions